International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
A Review on Molecular Mechanism of Antiepileptic Drugs
| Author(s) | Thsapimong C. Sangtam |
|---|---|
| Country | India |
| Abstract | This review paper delves into epilepsy and molecular mechanisms of selected AEDs (anti-epileptic drugs): CBZ (Carbamazepine), VPA (Valproate), PHT (Phenytoin), Topiramate (TPM), Lamotrigine (LTG), and Levetiracetam (LEV). Epilepsy is a neurological disorder categorized by recurrent seizures, which can affect the mental, psychological, and social well-being of an individual. Carbamazepine, an imino-dibenzyl derivative, acts by blocking voltage-gated sodium channels, modulating neuronal firing frequency, and inhibiting high-frequency firing. Phenytoin, a barbiturate derivative, inhibits collagenase activity and influences sodium and calcium fluxes. Valproate, a simple branched-chain fatty acid, exerts its effects on GABA and inhibitory neurotransmission, excitatory neurotransmission, monoamines, ion channels, and cerebral glucose metabolism. Topiramate, a broad-spectrum anti-epileptic drug, functions by blocking voltage-gated Ca2+ and Na+ channels, enhancing GABA-mediated neurotransmission, inhibiting glutamate-mediated neurotransmission, and inhibiting carbonic anhydrase isoenzymes. Lamotrigine, a phenyl-triazine compound that is chemically distinct from existing antiepileptic drugs (AEDs), inhibits voltage-gated sodium and calcium channels, thereby demonstrating antiseizure activity. Levetiracetam, another broad-spectrum AED, shows efficacy and tolerability superior to other AEDs, particularly in managing seizures and treating juvenile myoclonic epilepsy. It operates through a distinct mechanism by interacting with synaptic vesicle protein 2A (SV2A), setting it apart as a second-generation anticonvulsant. Therefore, understanding the molecular mechanisms of AEDs is essential for managing epilepsy effectively, improving seizure control, and enhancing living standards. This can also drive clinical advancements with the perspective of avoiding the adverse effects of AEDs. With a diverse range of AEDs available, there is hope for individuals having epilepsy to accomplish a satisfying quality of life. |
| Keywords | Molecular Mechanism AND (Antiepileptic Drugs OR Anticonvulsant Drugs OR AEDs) AND (Carbamazepine OR CBZ) AND (Phenytoin OR PHT) AND (Valporic acid OR Valproate OR VPA) AND (Topiramate OR TPM) AND (Lamotrigine OR LTG) AND (Levetiracetam OR LEV). |
| Field | Biology > Medical / Physiology |
| Published In | Volume 6, Issue 6, November-December 2024 |
| Published On | 2024-12-24 |
| DOI | https://doi.org/10.36948/ijfmr.2024.v06i06.33763 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals